ArticleJournal of medical virology2020
Convalescent plasma therapy: A passive therapy for an aggressive COVID-19.
Article in Journal of medical virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.JMIR public health and surveillance · 2021Pooled it
- Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease.Scientific reports · 2021Trial
- Clinical nursing care protocol for convalescent plasma transfusion in patients with COVID-19.International journal of Africa nursing sciences · 2023Article
- Role of 2-Deoxy-D-Glucose (2-DG) in COVID-19 disease: A potential game-changer.Journal of family medicine and primary care · 2021Review
- The importance of determining the amount of 'therapeutic units' before using convalescent plasma.Future virology · 2021Article
- Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19.Journal of thrombosis and thrombolysis · 2021Review
- Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.Laboratory medicine · 2021Review
- Current Perspectives of convalescent plasma therapy in COVID-19.Acta bio-medica : Atenei Parmensis · 2020Review
- Trajectory of the COVID-19 pandemic: chasing a moving target.Annals of translational medicine · 2020Review
- COVID-19 Pandemic and Children: A Review.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2020Review
- COVID-19: Imbalanced Immune Responses and Potential Immunotherapies.Frontiers in immunologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.